Table 1.
Demographic characteristics and genotypes of 24 subjects in the single-dose study of gliclazide MR
| Genotype | Genotype | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subject | Age (years) | Weight (kg) | CYP2C9 | CYP2C19 | Subject | Age (years) | Weight (kg) | CYP2C9 | CYP2C19 |
| 1 | 22 | 70 | *1/*1 | *1/*2 | 13 | 20 | 66 | *1/*1 | *1/*3 |
| 2 | 22 | 57 | *1/*1 | *1/*1 | 14 | 23 | 70 | *1/*3 | *1/*1 |
| 3 | 21 | 68 | *1/*1 | *1/*2 | 15 | 21 | 65 | *1/*3 | *1/*2 |
| 4 | 22 | 52 | *1/*1 | *1/*1 | 16 | 21 | 70 | *1/*3 | *1/*1 |
| 5 | 21 | 67 | *1/*1 | *1/*3 | 17 | 22 | 60 | *1/*3 | *1/*1 |
| 6 | 20 | 56 | *1/*1 | *1/*3 | 18 | 22 | 60 | *1/*3 | *1/*1 |
| 7 | 22 | 60 | *1/*1 | *1/*2 | 19 | 22 | 56 | *1/*3 | *1/*1 |
| 8 | 23 | 58 | *1/*1 | *1/*3 | 20 | 22 | 75 | *1/*3 | *1/*2 |
| 9 | 26 | 70 | *1/*1 | *2/*3 | 21 | 23 | 68 | *1/*3 | *1/*1 |
| 10 | 21 | 57 | *1/*1 | *2/*2 | 22 | 22 | 65 | *1/*13 | *1/*2 |
| 11 | 21 | 57 | *1/*1 | *1/*1 | 23 | 23 | 66 | *1/*13 | *1/*2 |
| 12 | 22 | 80 | *1/*1 | *1/*2 | 24 | 30 | 60 | *1/*13 | *2/*2 |